MedTrace Logo

GeneMatch: A Program of the Alzheimer's Prevention Registry to Match Individuals to Studies Based on Apolipoprotein E (APOE) Genotype

NCT02564692 · Status: ENROLLING_BY_INVITATION · Type: OBSERVATIONAL · Enrollment: 500000

Last updated 2025-12-09

No results posted yet for this study

Summary

The purpose of the Alzheimer's Prevention Registry GeneMatch program is to identify a large group of people interested in participating in research studies or clinical trials based in part on their genetic background. This genetic information will be used to match interested individuals to studies, providing a recruitment resource to the Alzheimer's scientific community. Interested individuals should visit www.endALZnow.org/GeneMatch to join the GeneMatch program.

Conditions

  • Alzheimer Disease

Sponsors & Collaborators

  • Banner Health

    lead OTHER

Principal Investigators

  • Jessica B Langbaum, PhD · Banner Alzheimer's Institute

Eligibility

Min Age
50 Years
Max Age
90 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2015-11-30
Primary Completion
2030-12-31
Completion
2030-12-31

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02564692 on ClinicalTrials.gov